Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
- PMID: 15546503
- PMCID: PMC11159131
- DOI: 10.1111/j.1349-7006.2004.tb02195.x
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
Abstract
BRCA1 (BReast-CAncer susceptibility gene 1) and BRCA2 are tumor suppressor genes, the mutant phenotypes of which predispose to breast and ovarian cancers. Intensive research has shown that BRCA proteins are involved in a multitude of pivotal cellular processes. In particular, both genes contribute to DNA repair and transcriptional regulation in response to DNA damage. Recent studies suggest that BRCA proteins are required for maintenance of chromosomal stability, thereby protecting the genome from damage. New data also show that BRCAs transcriptionally regulate some genes involved in DNA repair, the cell cycle, and apoptosis. Many of these functions are mediated by a large number of cellular proteins that interact with BRCAs. The functions of BRCA proteins are also linked to distinct and specific phosphorylation events; however, the extent to which phosphorylation-activated molecular pathways contribute to tumor suppressor activity remains unclear. Finally, the reasons why mutations in BRCA genes lead to the development of breast and ovarian cancers are not clearly understood. Elucidation of the precise molecular functions of BRCAs is expected to improve our understanding of hereditary as well as sporadic mammary carcinogenesis.
Similar articles
-
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.Front Biosci (Landmark Ed). 2014 Jan 1;19(4):605-18. doi: 10.2741/4230. Front Biosci (Landmark Ed). 2014. PMID: 24389207 Free PMC article. Review.
-
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.Hum Mol Genet. 2001 Apr;10(7):705-13. doi: 10.1093/hmg/10.7.705. Hum Mol Genet. 2001. PMID: 11257103 Review.
-
Cancer susceptibility and the functions of BRCA1 and BRCA2.Cell. 2002 Jan 25;108(2):171-82. doi: 10.1016/s0092-8674(02)00615-3. Cell. 2002. PMID: 11832208 Review.
-
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.Carcinogenesis. 2010 Jun;31(6):961-7. doi: 10.1093/carcin/bgq069. Epub 2010 Apr 16. Carcinogenesis. 2010. PMID: 20400477 Review.
-
BRCA1 gene in breast cancer.J Cell Physiol. 2003 Jul;196(1):19-41. doi: 10.1002/jcp.10257. J Cell Physiol. 2003. PMID: 12767038 Review.
Cited by
-
BRCA1 polymorphism in breast cancer patients from Argentina.Oncol Lett. 2015 Feb;9(2):845-850. doi: 10.3892/ol.2014.2772. Epub 2014 Dec 5. Oncol Lett. 2015. PMID: 25624909 Free PMC article.
-
Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.J Transl Med. 2021 Mar 16;19(1):108. doi: 10.1186/s12967-021-02772-y. J Transl Med. 2021. PMID: 33726785 Free PMC article.
-
BReast CAncer susceptibility gene 2 deficiency exacerbates oxidized LDL-induced DNA damage and endothelial apoptosis.Physiol Rep. 2020 Jul;8(13):e14481. doi: 10.14814/phy2.14481. Physiol Rep. 2020. PMID: 32638521 Free PMC article.
-
BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.Br J Cancer. 2013 Apr 2;108(6):1231-7. doi: 10.1038/bjc.2013.70. Epub 2013 Mar 5. Br J Cancer. 2013. PMID: 23462720 Free PMC article. Clinical Trial.
-
The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer.Thorac Cancer. 2023 Feb;14(5):497-505. doi: 10.1111/1759-7714.14772. Epub 2023 Jan 2. Thorac Cancer. 2023. PMID: 36594104 Free PMC article.
References
-
- Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003; 196: 19–41. - PubMed
-
- Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. Linkage of early‐onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–9. - PubMed
-
- Smith SA, Easton DF, Evans DG, Ponder BA. Allele losses in the region 17ql2–21 in familial breast and ovarian cancer involve the wild‐type chromosome. Nat Genet 1992; 2: 128–31. - PubMed
-
- Neuhausen SL, Marshall CJ. Loss of heterozygosity in familial tumors from three BRCAl‐linked kindreds. Cancer Res 1994; 54: 6069–72. - PubMed
-
- Miki Y, Swensen J, Shattuck‐Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous